John Northcott
2020
In 2020, John Northcott earned a total compensation of $3.8M as Senior Vice President and Chief Commercial Officer at Nektar Therapeutics, a 40% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $364,500 |
|---|---|
| Option Awards | $1,071,122 |
| Salary | $675,000 |
| Stock Awards | $1,604,292 |
| Other | $117,884 |
| Total | $3,832,798 |
Northcott received $1.6M in stock awards, accounting for 42% of the total pay in 2020.
Northcott also received $364.5K in non-equity incentive plan, $1.1M in option awards, $675K in salary and $117.9K in other compensation.
Rankings
In 2020, John Northcott's compensation ranked 2,986th out of 13,090 executives tracked by ExecPay. In other words, Northcott earned more than 77.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,986 out of 13,090 | 77th |
Division Manufacturing | 1,161 out of 5,621 | 79th |
Major group Chemicals And Allied Products | 437 out of 2,254 | 81st |
Industry group Drugs | 379 out of 1,954 | 81st |
Industry Pharmaceutical Preparations | 280 out of 1,459 | 81st |
Source: SEC filing on April 30, 2021.
Northcott's colleagues
We found four more compensation records of executives who worked with John Northcott at Nektar Therapeutics in 2020.